医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

HealthEdge Announces Inauguration of its India Operations Delivery Center in Pune

2021年10月11日 PM12:00
このエントリーをはてなブックマークに追加


 

BENGALURU, India

HealthEdge said today it is opening a new office Tuesday, Oct. 12, in Hinjewadi, the IT heart of Pune, with the intent to create as many as 150 new jobs in the area over the next two years, doubling its current India workforce. Recruitment is now underway. HealthEdge is a U.S.-based software company, leading the industry with integrated financial, administrative, and clinical platforms for health insurers. The world-class facility in Pune will operate as an India Operations delivery center.

The invitation-only Inauguration Event will be attended by a small number of in-person guests and will feature a livestream option for HealthEdge’s global community and media.

“We are excited and proud to be opening a state-of-the-art facility in Pune,” said Shivi Mithal, HealthEdge Vice President and Head of the India Delivery Center. “Setting up a HIPAA-compliant delivery center allows us to provide broader services and support to our U.S.-based customers. This capability will optimize customer value and satisfaction.”

The Pune center expands HealthEdge’s presence beyond Bangalore and Hyderabad and is actively recruiting staff in engineering, technical operations, dev-ops, and support. HealthEdge has a global footprint of more than 1,200 employees and has won numerous awards as a top place to work in recent years. The HealthEdge India operations center will house multiple teams in a green-certified facility spanning 4,500 square feet. It will serve a thriving business developing next-generation solutions for health insurance plans.

As a portfolio company of Blackstone, HealthEdge is well-positioned for success in the U.S. healthcare ecosystem. HealthEdge acquired Burgess and Altruista in 2020.

“HealthEdge has tremendous momentum as an organization and is positioned to scale for growth,” said Steve Krupa, CEO of HealthEdge. “Our Pune center aligns with our growth strategy and will be a hub for great tech talent, with the tools and technology to innovate and succeed together in a positive culture.”

Shivi noted that while the facility is built out and ready to accommodate new staff, it will offer continued remote-work options, with employee safety the top priority during the pandemic. India leadership continues to closely monitor the pandemic. Visit healthedge.com for job openings in the Pune facility.

About HealthEdge

HealthEdge® is the health insurance industry’s first digital nervous system to provide automation and seamless connectivity between all parts of a payer’s administrative and clinical systems. HealthEdge provides modern, disruptive healthcare IT solutions that health insurers use to leverage new business models, improve outcomes, drastically reduce administrative costs, and connect everyone in the healthcare delivery cycle. Its next-generation enterprise solution suite is built on modern, patented technology and is delivered to customers via the HealthEdge Cloud or onsite deployment. In 2020, funds managed by Blackstone became the majority owner. HealthEdge and its portfolio of mission-critical technology assets for payers, including The Burgess Group and Altruista Health, are collectively driving a digital transformation in healthcare. Follow HealthEdge on Twitter or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211010005027/en/

CONTACT

Rajlaxmi Shinde (India)

+91-8007996200 | rshinde@healthedge.com

Lori Taylor (US)

813-220-9702 | ltaylor@healthedge.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease